Loading chat...
US HB7407
Bill
Status
2/5/2026
Primary Sponsor
Frank Pallone
Click for details
AI Summary
-
Prohibits introducing into interstate commerce any product marketed as a dietary supplement that does not meet the legal definition of a dietary supplement under Section 201(ff) of the Federal Food, Drug, and Cosmetic Act
-
Bans dietary supplements prepared, packed, or held with assistance from persons debarred under Section 306 of the Act
-
Expands FDA import exclusion authority to block entry of products violating the new prohibited acts at U.S. borders
-
Grants FDA new seizure authority to confiscate products that violate these provisions, adding them to existing enforcement mechanisms under Section 304
-
Amends Section 301 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 331) by adding two new prohibited act categories (jjj) and (kkk)
Legislative Description
Prohibiting Tianeptine and Other Dangerous Products Act of 2026
Health
Last Action
Referred to the House Committee on Energy and Commerce.
2/5/2026